<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="433">
  <stage>Registered</stage>
  <submitdate>7/09/2005</submitdate>
  <approvaldate>5/10/2005</approvaldate>
  <actrnumber>ACTRN12605000598684</actrnumber>
  <trial_identification>
    <studytitle>Remineralisation of decalcified tooth enamel consequent to orthodontic treatment</studytitle>
    <scientifictitle>Remineralisation of decalcified tooth enamel following routine application of fluoride or casein phosphopeptide - amorphous calcium phosphate during in individuals undergoing orthodontic treatment</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Enamel demineralisation</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Enamel demineralization is a frequent finding during orthodontic treatment, and is associated with poor oral hygiene.  This study is directed at determining the optimum agent (or combination of agents) and techniques that will promote maximum resolution of the demineralised enamel lesions.  The agents under investigation include single application of Ozone, and routine use of fluoride and casein phosphopeptide - amorphous calcium phosphate.</interventions>
    <comparator />
    <control>Historical</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary outcome that is expected is gradual resolution of the enamel lesions over a period of time.</outcome>
      <timepoint>Assessment of the changes will be made every 4 weeks.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Early detection of enamel lesions and appropriate application of the optimum therapeutic agent to halt and reverse the demineralisation process.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>The presence of demineralised enamel lesions.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Allergy to milk products.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed envelopes.</concealment>
    <sequence>Block randomisation ie a given number of sealed envelopes are placed within another, and selection (ie generation) is by random selection of envelopes such that within the given block, there will be a certain number within each category.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Each subject serves as their own control (at baseline)</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>9/04/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1500</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Andrew Quick</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Successful research grant</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrew Quick</name>
      <address>School of Dentistry
Discipline of Orthodontics
University of Otago
Box 647
Dunedin</address>
      <phone>+64 3 4797068</phone>
      <fax>+64 3 4797070</fax>
      <email>andrew.quick@stonebow.otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Andrew Quick</name>
      <address>School of Dentistry
Discipline of Orthodontics
University of Otago
Box 647
Dunedin</address>
      <phone>+64 3 4797068</phone>
      <fax>+64 3 4797070</fax>
      <email>andrew.quick@stonebow.otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>